SavedAdd your journal

Journals / Dicle Tıp Dergisi / 2026 / Cilt: 39 Sayı: 3

Metabolik sendromlu hastalarda aortun elastik özellikleri ve aort sertliğini etkileyen faktörler [Elastic properties of the aorta and factors affecting aortic stiffness in patients with metabolic syndrome]

Metabolik sendromlu hastalarda aortun elastik özellikleri ve aort sertliğini etkileyen faktörler

Derya Tok
Fırat Özcan
İskender Kadife
Osman Turak
Nurcan Başar
Kumral Çağlı
Sinan Aydoğdu
Pages
365–370
Publication Date
2012-09-01
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the MetS patients, aortic distensibility was significantly decreased (10.4±3.5 cm2.dyn-1.10-6 vs. 12.7±3.4 cm2.dyn-1.10-6, p=0.002), and ASI was significantly increased (6.5±2.0 vs. 3.2±0.8, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: In this study, we evaluated aortic stiffness and echocardiographic and laboratory factors affecting aortic stiffness in patients with metabolic syndrome (MetS).
📊
Key Findings & Data:Materials and methods: Forty-six patients (25 male, mean age 47.3±6.5 years) with the diagnosis of MetS according to the Adult Treatment Panel III Final Report criteria were included.
💡
Conclusion & Impact:In the MetS patients, aortic distensibility was significantly decreased (10.4±3.5 cm2.dyn-1.10-6 vs. 12.7±3.4 cm2.dyn-1.10-6, p=0.002), and ASI was significantly increased (6.5±2.0 vs. 3.2±0.8, p
🔬Design:Makale
📍Scope:Comprehensive Sample
⚙️Variables:Metabolik sendrom · Ekokardiyografi · Aortun elastik özellikleri

Abstract

Objectives: In this study, we evaluated aortic stiffness and echocardiographic and laboratory factors affecting aortic stiffness in patients with metabolic syndrome (MetS). Materials and methods: Forty-six patients (25 male, mean age 47.3±6.5 years) with the diagnosis of MetS according to the Adult Treatment Panel III Final Report criteria were included. Forty-four age and gender matched healthy subjects (18 male, mean age 46.0±6.1 years) were recruited as the control group. Aortic strain, distensibility and stiffness index were calculated by M-mode echocardiography and diastolic parameters were measured. Results: Left ventricular mass index (LVMI), deceleration time (DT), isovolumic relaxation time (IVRT) were increased and mitral E/A ratio was decreased in patients with MetS compared to controls. In the MetS patients, aortic distensibility was significantly decreased (10.4±3.5 cm2.dyn-1.10-6 vs. 12.7±3.4 cm2.dyn-1.10-6, p=0.002), and ASI was significantly increased (6.5±2.0 vs. 3.2±0.8, p

Özet

Amaç: Metabolik sendromda aortik sertlikte artış olması beklenmektedir. Çalışmamızda metabolik sendrom (MetS)\'lu hastalarda aortik sertlik ve bununla ilişkili ekokardiyografik ve biyokimyasal parametreleri saptamayı amaçladık. Gereç ve yöntem: Çalışmaya güncellenmiş ATP III kriterlerine göre MetS tanısı alan ardışık 46 hasta (25 erkek, ortalama yaş 47.3±6.6 yıl) ve 44 kontrol (18 erkek, ortalama yaş 46.0±6.1yıl) hastası alındı. M-mode ekokardiyografi ile aortik strain, distensibilite ve sertlik indeksi hesaplandı. Ekokardiyografik olarak diastolik parametrelerin ölçümü yapıldı. Bulgular: Ekokardiyografik parametrelerden sol ventrikül kitle indeksi, deselerasyon zamanı (DZ), izovolümetrik relaksasyon zamanı (İVRZ) MetS\'lu hastalarda kontrol grubuna kıyasla yüksek ve mitral E/A oranı ise düşük saptandı. MetS\'lu hastalarda kontrol grubuna kıyasla aortik distensibilite anlamlı düşük (10.4±3.5\'e cm2.dyn-1.10-6 karşılık 12.7±3.4 cm2.dyn-1.10-6, p=0.002), sertlik indeksi ise anlamlı yüksek saptandı (6.5±2.0\'e karşılık 3.2±0.8, p

🔖

Cite This Article

Tok, D., Özcan, F., Kadife, İ., Turak, O., Başar, N., Çağlı, K., Aydoğdu, S. (2012). Metabolik sendromlu hastalarda aortun elastik özellikleri ve aort sertliğini etkileyen faktörler [Elastic properties of the aorta and factors affecting aortic stiffness in patients with metabolic syndrome]. Dicle Tıp Dergisi, Cilt: 39 Sayı: 3, 365–370. https://doi.org/10.5798/diclemedj.0921.2012.03.0159

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (31)

  1. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008;28(4):629-36.
  2. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006;119(10):812-9.
  3. Motillo S, Filion KB, Genest J, et al. The metabolic syn- drome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010;56(14):1113-32.
  4. Zanetti M, Bosutti A, Ferreira C, et al. Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile. Clin Exp Med 2009;9(3):243-8.
  5. Arnett DK, Evans GW, Rİley WA. Arterial stiffness a new cardiovascular risk factor. Am J Epidemiol. 1994;140(8):669682.
  6. Kostis J, Lawrence-Nelson J, Ranjan R, Wilson A, Kostis W, Lacy C. Association of increased pulse pressure with the development of heart failure in SHEP.Systolic Hyperten- sion in the Elderly (SHEP) Cooperative ResearchGroup. Am J Hypertens 2001;14(8):798–803.
  7. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM.Impact of aortic stiffness on survival in end- stage renal disease. Circulation 1999;99(18):2434–9.
  8. Benetos A, Safar M, Rudnichi A, et al. Pulse pressure: a predictor of long-term cardiovascular mortality in a french male population. Hypertension 1997;30(6):1410–5.
  9. Benetos A, Laurent S, Hoeks AP, Boutouyrie PH, Safar ME. Arterial alterations with aging and high blood pressure. A noninvasive study of carotid and femoral arteries. Arterio- scler Thromb 1993;13(1):90 –7.
  10. Lacombe F, Dart A, Dewar E, et al. Arterial elastic proper- ties in man: a comparison of echo–Doppler indices of aortic stiffness. Eur Heart J 1992;13(8):1040-5.
  11. Nicole M, Van Popole MD, Diederick E. Association be- tween arterial stiffness and atherosclerosis. The Rotterdam Study. Stroke 2001;32(2):454-60.
  12. Third Report of the National Education Program (NCEP) Expert Panel on Detection,Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143-421.
  13. Lenfant C, Chobanian AV, Jones DW et al. Seventh report of the Joint National Committee on the Prevention, Detec- tion, Evaluation, and Treatment of High Blood Pressure (JNC 7):resetting the hypertension sails. Hypertension 2003;41(6):1178-9.
  14. Cheitlin MD, Alpert JS, Armstrong WF et al. ACC/AHA guidelines fort he clinical application of echocardiography. A report of the American College of Cardiology/Ameri- can Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. Circulation 1997;95(6):1686-744.
  15. Devereux RB, Reichek N. Echocardiographic determina- tion of the left ventricular mass in man. Anatomic valida- tion of the method. Circulation 1977;55(4):613-8.
  16. Stefanadis C, Stratos C, Boudoulas H, Kourouklis C, Tou- touza P. Distensibility of the ascending aorta: compari- son of invasive and non-invasive techniques in healthly men and in men with coronary artery disease. Eur Heart J 1990;11(11):990-6.
  17. D’Andrea A, Cocchia R, Reigler L, et al. Aortic stiffness and distensibility in top-level athletes. J Am Soc Echocar- diography 2012;25(5):561-7.
  18. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovas- cular mortality in hypertensive patients. Hypertension 2001;37(5):1236-41.
  19. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease?The Framingham Heart Study. Circulation 1999;100(4):354-60.
  20. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288(21):2709-16.
  21. Ford ES. The metabolic syndrome and mortality from car- diovascular disease and all-causes: Findings from the Na- tional Health and Nutrition Examination Survey II Mortal- ity Study. Atherosclerosis 2004;173(2):309-14.
  22. Satoh H, Kishi R, Tsutsui H. Metabolic syndrome is a signif- icant and independent risk factor for increased arteriel stiff- ness in Japanes subjects. Hypertens Res 2009;32(12):1067- 71.
  23. Li CI, Kardia S, Liu CS, et al. Metabolic syndrome is asso- ciated with change in subclinical arteriel stiffness- A com- munity-based Taichung Community Health Study. BMC Public Health 2011;11:808-16.
  24. van Popele NM, westendorp IC, Bots ML, et al. Variables of the insulin resistance syndrome are associated with reduced arterial distensibility in healthly non-diabetic middle-aged women. Diabetologia 2000;43(5):665-72.
  25. Sutton-Tyrell K, Newman A, Simonsick EM, et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composi- tion. Hypertension 2001;38(3):429-33.
  26. Emre A, Oz D, Yesilcimen K, Sayar N, Ergun D. Impact of the metabolic syndrome on aortic pulse pressure and as- cending aortic pulsatility in patients with angiographically normal coronary arteries. Can J Cardiol 2009;25(7):411-4.
  27. Stehouwer CD, Henry RM, Ferreira I. Arteriel stiffness in diabetes and the metabolic syndrome:a pathway to cardio- vascular disease. Diabetologia 2008;51(4):527-39.
  28. Schillaci G, Pirro M, Vaudo G, et al. Metabolic syndrome is associated with aortic stiffness in untreated essential hyper- tension. Hypertension 2005;45(6):1078-82.
  29. Sipila K, Koivistoinen T, Moilanen L, et al. Metabolic syndrome and arteriel stiffness: The Health 2000 Survey. Metab Clin Expl 2007;56(3):320-6.
  30. Eren M, Gorgulu S, Uslu N, et al. Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both. Heart 2004; 90(1):37- 43.
  31. Third Report of the National Education Program (NCEP) Expert Panel on Detection,Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143-421.